top of page
Nanomaterials to Program the Immune System
A Research Lab at Boston University
Research in the Teplensky Lab focuses on engineering nanotechnology to control immunological cell connectivity, processing, and communication by design. In doing so, we elucidate fundamentals about cellular events and leverage this knowledge to develop improved therapeutics and vaccines that can impact the treatment of cancer and infectious disease.
We aim to develop and incorporate synthetic nanoscale advances to control immunological activity and elucidate design rules that have widespread impacts on therapeutic development.
To play, press and hold the enter key. To stop, release the enter key.
bottom of page